
Robert A. Wax
Supervisory Patent Examiner (ID: 262, Phone: (571)272-0623 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1805, 1105, 1656, 1506, 1507, 1814, 1652, 1615, 1807, 1653, 1808 |
| Total Applications | 1637 |
| Issued Applications | 935 |
| Pending Applications | 421 |
| Abandoned Applications | 282 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 679424
[patent_doc_number] => 07083931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Renilla GFP mutants with increased fluorescent intensity and spectral shift'
[patent_app_type] => utility
[patent_app_number] => 10/815337
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 48
[patent_no_of_words] => 23156
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/083/07083931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815337 | Renilla GFP mutants with increased fluorescent intensity and spectral shift | Mar 31, 2004 | Issued |
Array
(
[id] => 686450
[patent_doc_number] => 07078165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 10/808735
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11183
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808735
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808735 | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof | Mar 24, 2004 | Issued |
Array
(
[id] => 607526
[patent_doc_number] => RE039436
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-12-19
[patent_title] => 'Interventions to mimic the effects of calorie restriction'
[patent_app_type] => reissue
[patent_app_number] => 10/807554
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20658
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807554 | Interventions to mimic the effects of calorie restriction | Mar 21, 2004 | Issued |
Array
(
[id] => 7168599
[patent_doc_number] => 20050202079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation'
[patent_app_type] => utility
[patent_app_number] => 10/800031
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5475
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800031 | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation | Mar 14, 2004 | Abandoned |
Array
(
[id] => 627221
[patent_doc_number] => 07135605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-14
[patent_title] => 'Metal binding proteins and associated methods'
[patent_app_type] => utility
[patent_app_number] => 10/797748
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 11505
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797748 | Metal binding proteins and associated methods | Mar 8, 2004 | Issued |
Array
(
[id] => 7276258
[patent_doc_number] => 20040235709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Gssp3 polynucleotides and polypeptides and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/467046
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42813
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467046 | Gssp3 polynucleotides and polypeptides and uses thereof | Mar 7, 2004 | Abandoned |
Array
(
[id] => 7263395
[patent_doc_number] => 20040241695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Hemocyanin nucleic acids and polypeptides and related vectors fusion protein conjugates cells and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/488824
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 15101
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10488824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488824 | Hemocyanin nucleic acids and polypeptides and related vectors fusion protein conjugates cells and methods of use | Mar 4, 2004 | Abandoned |
Array
(
[id] => 6944710
[patent_doc_number] => 20050196759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Transductin-1 and transductin-2 and applications to hereditary deafness'
[patent_app_type] => utility
[patent_app_number] => 10/792307
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15324
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792307
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792307 | Transductin-1 and transductin-2 and applications to hereditary deafness | Mar 2, 2004 | Issued |
Array
(
[id] => 612936
[patent_doc_number] => 07148334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs'
[patent_app_type] => utility
[patent_app_number] => 10/791059
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 13
[patent_no_of_words] => 8512
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791059 | Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs | Mar 1, 2004 | Issued |
Array
(
[id] => 620132
[patent_doc_number] => 07141547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Albumin fusion proteins comprising GLP-1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/775204
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 208580
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775204 | Albumin fusion proteins comprising GLP-1 polypeptides | Feb 10, 2004 | Issued |
Array
(
[id] => 7323707
[patent_doc_number] => 20040137505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Gram-positive microorganisms with an inactivated cysteine protease-2'
[patent_app_type] => new
[patent_app_number] => 10/773914
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6939
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773914
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773914 | Gram-positive microorganisms with an inactivated cysteine protease-2 | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7348465
[patent_doc_number] => 20040248255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Leukocyte stimulating peptides'
[patent_app_type] => new
[patent_app_number] => 10/774147
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11912
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10774147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/774147 | Leukocyte stimulating peptides | Feb 4, 2004 | Issued |
Array
(
[id] => 7675250
[patent_doc_number] => 20040126868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Gram-positive microorganisms with an inactivated cysteine protease-3'
[patent_app_type] => new
[patent_app_number] => 10/773387
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6943
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126868.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773387 | Gram-positive microorganisms with an inactivated cysteine protease-3 | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7147942
[patent_doc_number] => 20040170590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Water-soluble silk proteins in compositions for skin care, hair care or hair coloring'
[patent_app_type] => new
[patent_app_number] => 10/772124
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13319
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170590.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772124 | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring | Feb 3, 2004 | Issued |
Array
(
[id] => 488971
[patent_doc_number] => 07214513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Transcriptional regulatory factor'
[patent_app_type] => utility
[patent_app_number] => 10/754342
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 11474
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754342
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754342 | Transcriptional regulatory factor | Jan 8, 2004 | Issued |
Array
(
[id] => 7402879
[patent_doc_number] => 20040175429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Biodegradable microparticles that stabilize and control the release of proteins'
[patent_app_type] => new
[patent_app_number] => 10/750475
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9909
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10750475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/750475 | Biodegradable microparticles that stabilize and control the release of proteins | Dec 30, 2003 | Issued |
Array
(
[id] => 813390
[patent_doc_number] => 07413748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Transdermal buprenorphine to treat pain in sickle cell crisis'
[patent_app_type] => utility
[patent_app_number] => 10/736049
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/413/07413748.pdf
[firstpage_image] =>[orig_patent_app_number] => 10736049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/736049 | Transdermal buprenorphine to treat pain in sickle cell crisis | Dec 14, 2003 | Issued |
Array
(
[id] => 7672955
[patent_doc_number] => 20040180824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Combination treatment using exendins and thiazolidinediones'
[patent_app_type] => new
[patent_app_number] => 10/726734
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7964
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726734 | Combination treatment using exendins and thiazolidinediones | Dec 2, 2003 | Abandoned |
Array
(
[id] => 7168761
[patent_doc_number] => 20040077539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => '$g(a)-lactalbumin as prebiotic agent'
[patent_app_type] => new
[patent_app_number] => 10/467005
[patent_app_country] => US
[patent_app_date] => 2003-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4474
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467005
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467005 | $g(a)-lactalbumin as prebiotic agent | Nov 27, 2003 | Abandoned |
Array
(
[id] => 7322706
[patent_doc_number] => 20040137133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Process for extracting flax protein concentrate from flax meal'
[patent_app_type] => new
[patent_app_number] => 10/722124
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3024
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722124 | Process for extracting flax protein concentrate from flax meal | Nov 25, 2003 | Issued |